Millennium Management Portfolio holdings
Millennium Management is a multistrategy hedge fund firm, started in 1989 by Israel Englander along with Ronald Shear, an acquaintance from the American Stock Exchange who left after six months. Englander remains its principal. It works as a platform: many separate investment teams, each with a portfolio manager given money to trade in a variety of strategies. Its teams research and pick individual companies, run computer-driven strategies, and trade fixed income, commodities and credit. In 2018 it launched a joint venture with WorldQuant, a computer-driven investment firm. Its clients include state and local government bodies and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.56% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4151
CALL
On Holding
ONON
$12.5B
| $1.07M | ﹤0.01% |
30,200
+15,200
| +101% | +$556K |
2024 Q2
8 quarters
|
|
4152
Rithm Property Trust
RPT
$87M
| $1.07M | ﹤0.01% |
+74,242
| New | +$1.07M |
2026 Q2
0 quarters
|
|
4153
Nexxen International
NEXN
$503M
| $1.07M | ﹤0.01% |
118,368
+104,206
| +736% | +$822K |
2025 Q4
2 quarters
|
|
4154
Parke Bancorp
PKBK
$384M
| $1.07M | ﹤0.01% |
32,174
+5,302
| +20% | +$163K |
2024 Q4
6 quarters
|
|
4155
CALL
USA Rare Earth Inc
USAR
$3.09B
| $1.07M | ﹤0.01% |
+49,400
| New | +$1.13M |
2026 Q2
0 quarters
|
|
4156
TuHURA Biosciences
HURA
$104M
| $1.06M | ﹤0.01% |
+454,535
| New | +$1.06M |
2026 Q2
0 quarters
|
|
4157
CALL
CarMax
KMX
$7.31B
| $1.06M | ﹤0.01% |
20,100
-62,500
| -76% | -$2.72M |
2025 Q2
4 quarters
|
|
4158
Porch Group
PRCH
$2.26B
| $1.06M | ﹤0.01% |
70,562
+21,932
| +45% | +$216K |
2024 Q4
6 quarters
|
|
4159
Immatics
IMTX
$968M
| $1.06M | ﹤0.01% |
104,710
-111,011
| -51% | -$1.17M |
2024 Q4
6 quarters
|
|
4160
CALL
POET Technologies
POET
$877M
| $1.06M | ﹤0.01% |
+102,900
| New | +$1.12M |
2026 Q2
0 quarters
|
|
4161
Business First Bancshares
BFST
$1.04B
| $1.05M | ﹤0.01% |
34,317
+7,182
| +26% | +$203K |
2024 Q2
8 quarters
|
|
4162
Invivyd
IVVD
$166M
| $1.05M | ﹤0.01% |
1,205,599
-2,305,982
| -66% | -$2.89M |
2025 Q2
4 quarters
|
|
4163
Arm
ARM
$186B
| $1.05M | ﹤0.01% |
2,949
-267,215
| -99% | -$71.1M |
2024 Q1
9 quarters
|
|
4164
Xeris Biopharma Holdings
XERS
$2.77B
| $1.04M | ﹤0.01% |
131,664
-2,134,310
| -94% | -$13.6M |
2023 Q2
12 quarters
|
|
4165
PUT
Capricor Therapeutics
CAPR
$523M
| $1.04M | ﹤0.01% |
+43,300
| New | +$1.31M |
2026 Q2
0 quarters
|
|
4166
Cantor Equity Partners VI
CEPS
$150M
| $1.04M | ﹤0.01% |
100,500
-2,500
| -2% | -$25.5K |
2026 Q1
1 quarter
|
|
4167
First Commonwealth Financial
FCF
$2.03B
| $1.04M | ﹤0.01% |
51,184
-517,292
| -91% | -$9.8M |
2024 Q2
8 quarters
|
|
4168
Perdoceo Education
PRDO
$1.68B
| $1.04M | ﹤0.01% |
32,392
-105,549
| -77% | -$3.62M |
2022 Q1
17 quarters
|
|
4169
iShares Russell 2000 Growth ETF
IWO
$13.6B
| $1.04M | ﹤0.01% |
2,628
+168
| +7% | +$61.3K |
2025 Q4
2 quarters
|
|
4170
Instil Bio
TIL
$46.3M
| $1.03M | ﹤0.01% |
134,575
+1,629
| +1% | +$13.1K |
2024 Q4
6 quarters
|
|
4171
Brightstar Lottery PLC
BRSL
$1.8B
| $1.03M | ﹤0.01% |
96,137
-955,415
| -91% | -$11.4M |
2025 Q3
3 quarters
|
|
4172
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15.1B
| $1.03M | ﹤0.01% |
12,400
-9,100
| -42% | -$760K |
2025 Q1
5 quarters
|
|
4173
CALL
Opendoor
OPEN
$1.36B
| $1.03M | ﹤0.01% |
+222,600
| New | +$1.07M |
2026 Q2
0 quarters
|
|
4174
GoodRx Holdings
GDRX
$1.2B
| $1.03M | ﹤0.01% |
356,654
+331,227
| +1,303% | +$842K |
2025 Q4
2 quarters
|
|
4175
Health Catalyst
HCAT
$110M
| $1.03M | ﹤0.01% |
+516,083
| New | +$745K |
2026 Q2
0 quarters
|
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.